Madely Health Headlines Commentary for March 1, 2010

Disease-modifying drug reduces brain protein plaques in Alzheimer patients Play Now | Play in Popup | Download

Source:

Neuroimaging technique shows potential of bapineuzumab treatment and might be useful in assessing other drugs for Alzheimer’s Disease

Reference:

11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer’s disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

Related articles:

1. Small phase 1 study shows electrical stimulation of the brain can help slow progression of Alzheimer Disease
2. More evidence to suggest that exercise may reduce risk of cognitive decline seen in Alzheimer patients
3. Observational data supports Mediterranean diet reduces Alzheimer risk
4. Basic science research trying to unravel the mechanism of Alzheimer’s disease
5. Progress in understanding how aging contributes to the development of Alzheimer Disease